Source: Health Sciences Authority (SG) Revision Year: 2021 Publisher: Manufacturer: General Drugs House Co.,Ltd., 2-4 Lardprao Road Soi 82, Bangkok, Thailand 10310
Venotonic and vascular protector.
It is active upon the return vascular system in the following way:
Double blind controlled studies using methods by which the effects of the product on venous haemodynamics could be demonstrated and quantified have confirmed the above pharmacological properties in man.
Double-blind placebo-controlled trials have demonstrated the activity of the drug in phlebology, in the treatment of chronic venous sufficiency of the lower limbs (both functional and organic).
In man, following oral administration of the substance containing Euvein:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.